Drugs / YH14659
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01657071 | Mar → Apr 2012 | acute coronary syndrome | Yuhan Corporation | Completed | No outcome recorded |
| Phase 1 | NCT01422109 | Jul → Nov 2011 | acute coronary syndrome | Yuhan Corporation | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YH14659 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01422109 ↗ |
| Route | Oral | “YH14659 capsule by oral” NCT01422109 ↗ |